SS
S SRINIVASA RAO Dirigeant
Other
IN IN · SEBI (PIT + SAST)
Discover the complete record of transactions filed by S SRINIVASA RAO, Dirigeant. Officer active across 1 companies, notably Gland Pharma Limited. Cumulatively, 22 filings have been logged. The latest transaction was disclosed on 26 February 2025 (Purchase). Regulator: SEBI (PIT + SAST). The full history is accessible without signup.
Declarations 22 total
€16,540 2,800 shares @ €5.9073
Equity Shares
SEBI:7219b733f3d9d15f3f9020dbc6a9bb12c9ff8b1e · 26 Feb 2025
Ideal exit: 23 Nov 2025 (T+270) €39,506 1,950 shares @ €20.2595
Equity Shares
SEBI:f0701641538c4b901e0b3a0d1fe4eb2e3ab8f5aa · 27 Jun 2024
€20,379 1,000 shares @ €20.3791
Equity Shares
SEBI:225d8f1f09305affbbab911ef21fc9afb4ad2b81 · 25 Jun 2024
€20,351 1,000 shares @ €20.3506
Equity Shares
SEBI:8b69af0f66e683207b9cbbeea8ecb5fd725d2aac · 24 Jun 2024
€80,142 4,000 shares @ €20.0354
Equity Shares
SEBI:fc4ffe6e94442749792b8cdb7cb9e050d5a8cfec · 14 Dec 2023
€48,800 1,500 shares @ €32.5332
Equity Shares
SEBI:452a3ddd22326b35d5092fdff51d6295a1901e35 · 30 Jun 2022
€32,076 1,000 shares @ €32.076
Equity Shares
SEBI:3459a3e70f99220c7398f98c3bfc3935db2d5709 · 28 Jun 2022
€16,083 500 shares @ €32.1653
Equity Shares
SEBI:116e0488eaf3ff78bc477558447e8dd3903d02ae · 27 Jun 2022
€32,472 1,000 shares @ €32.4718
Equity Shares
SEBI:749dd500e45e5714941ec85424b2198640d872aa · 21 Jun 2022
€23,187 3,500 shares @ €6.6249
Equity Shares
SEBI:a3ed60cd9d9d8ee54f3a3838e12aac013b8567a2 · 15 Jun 2022
Ideal exit: 12 Mar 2023 (T+270) €46,486 1,000 shares @ €46.4856
Equity Shares
SEBI:a87a5e7588dbd1369a97713f9c3a7652eb19ba1a · 30 Dec 2021
€23,157 500 shares @ €46.3148
Equity Shares
SEBI:6a5f5cd44e69f352912ce5b876d463dd6e611664 · 29 Dec 2021
€4,602 100 shares @ €46.0189
Equity Shares
SEBI:a9883260ad32d13bdfd7b49eb3a93079b74fe157 · 24 Dec 2021
€40,493 900 shares @ €44.9919
Equity Shares
SEBI:3b314990c30abac91fc247fd1af208cb845520f6 · 23 Dec 2021
€8,804 200 shares @ €44.0204
Equity Shares
SEBI:df69ae495b07dc6c11f77e3b2cef5c35e482b89d · 20 Dec 2021
€24,770 500 shares @ €49.54 0.0000% mcap 17.8% of flow
Equity Shares
SEBI:72f00f999fd5e5b9600e77ae3ff904af9ad3132d · 12 Aug 2021
€33,643 700 shares @ €48.0611 0.0000% mcap 24.2% of flow
Equity Shares
SEBI:aeccbaecc6610c36ba5999f1b869a775ac747f33 · 10 Aug 2021
€37,294 800 shares @ €46.6178 0.0000% mcap 26.9% of flow
Equity Shares
SEBI:5e180742f6022c3b2fa18a87ab372ae0f154568d · 5 Aug 2021
€32,177 700 shares @ €45.9669 0.0000% mcap 23.2% of flow
Equity Shares
SEBI:fe8e5f4168906d90189cc42cd8e2e4f92e5a8820 · 26 Jul 2021
€17,197 2,800 shares @ €6.1419 0.0000% mcap 100.0% of flow
Equity Shares
SEBI:0b8d023344a568a140c885b2bebcb9dd51806488 · 5 Jul 2021
Ideal exit: 1 Apr 2022 (T+270) €18,461 500 shares @ €36.9223 0.0000% mcap 100.0% of flow
Equity Shares
SEBI:c7d70a87f3ec82bf347a67464278c275849cd92a · 28 May 2021
€10,980 300 shares @ €36.6007 0.0000% mcap 7.9% of flow
Equity Shares
SEBI:a0556eaeeb72674c65219d967dae8102ae1c7c44 · 25 May 2021
About S SRINIVASA RAO S SRINIVASA RAO is associated with Gland Pharma Limited, an Indian company specializing in pharmaceutical manufacturing. While the specifics of his role are not specified, he plays a key role in the management of the company, which is committed to innovation and quality in the pharmaceutical sector.